The following summarizes the report contents by section:
SECTION I: Market Status, Trends and Forecasts
Analysis of recent sales, competitive challenges, new products in the pipeline and forces affecting future growth. Also provides sales forecasts to 2014. Products include:
- Nuclear cardiology (heart perfusion agents, pharmacologic stressors, blood pool agents, myocardial viability agents, and metabolic FDG imaging. New products include Zemiva (I-131 BMIPP) for imaging myocardial infarction and Andreview (I-123-MIBG) for congestive heart failure.
- Products for functional nuclear imaging including thyroid, bone, gall bladder, kidney, lung, liver and white blood cell labeling.
- Oncology products including ProstaScint, Octreoscan and new products for imaging breast cancer and multiple solid tumors as well as new PET imaging agents.
SECTION II: Radiopharmaceutical Products and Technology
- Technical principles and functional characteristics of radiopharmaceutical agents.
- Radioisotope selection and optimization; production methods and trade-offs.
SECTION III: Clinical Applications
- Discussion of clinical applications for radiopharmaceutical products and technologies.
- Options in radiopharmaceutical selection and opportunities in PET imaging.
- Analysis of product characteristics, performance benefits and trade-offs.
SECTION IV: Current Developments and Emerging Technologies
- Description of products in development within each major market segment including nuclear cardiology, neurology, targeted cancer imaging and infection imaging.
- Description of new diagnostic agents, such as receptor specific proteins, new myocardial imaging agents, angiogenesis imaging for cellular response to therapy, apoptosis imaging and therapy, PLE (phospho-lipid ether) targeting and therapy.
SECTION V: Industry Analysis
- Analysis of current suppliers with individual product sales and market shares in 2007
- Market distribution, pricing strategies and new products in the pipeline.
- Discussion of marketing goals, product plans, corporate partnerships and new ventures.
SECTION VI: End-User Analysis
- Analysis of end-user groups and comparative requirements for medical imaging.
- Procedure mix and product utilization in hospitals and clinics.
SECTION VII: Company Profiles
- Background information on companies in the field and review of recent performance.
- Discussion of each company's market activities and management strategies.
|
Back to Top
BTSI270.doc
-OR-
BTSI270.pdf
Send
this page to a friend